Have changes to the Scottish Medicines Consortium (SMC) process following the routledge review really improved access to Orphan Medications and what factors influence recommendations?

May 1, 2015, 00:00
10.1016/j.jval.2015.03.547
https://www.valueinhealthjournal.com/article/S1098-3015(15)00604-X/fulltext
Title : Have changes to the Scottish Medicines Consortium (SMC) process following the routledge review really improved access to Orphan Medications and what factors influence recommendations?
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)00604-X&doi=10.1016/j.jval.2015.03.547
First page : A93
Section Title : Research Poster Presentations - Session II
Open access? : No
Section Order : 1656
Categories :
Tags :
Regions :
ViH Article Tags :